Detalhe da pesquisa
1.
Genetic justification of COVID-19 patient outcomes using DERGA, a novel data ensemble refinement greedy algorithm.
J Cell Mol Med
; 28(4): e18105, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38339761
2.
Pre-Emptive Use of Rituximab in Epstein-Barr Virus Reactivation: Incidence, Predictive Factors, Monitoring, and Outcomes.
Int J Mol Sci
; 24(22)2023 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38003218